Brain47Brain47Join Brain47
43Z

Schrödinger, Inc.

Healthcare · EUR · F

43Z

Price

€11.10

+7.03%

Cap

€981.08M

Earnings

—

30d Trend

+2.1%

43Z
Loading chart data...
0 days · % change from startPowered by Brain47
52-week range25%
€9.42€16.14

Lower half of range — may offer entry value

VolatilityHigh

57% annualised over 90 days

BRAIN47 SIGNAL

0
WEAK
Risk Level85
Quality45
Momentum32
Technical51
Fundamentals32

Raw weighted: 34×Macro 0.99 (−1%)=34

RISK LEVEL

85/100
90d Volatility
56.7%High
ATR %
5.7%High daily moves
Max Drawdown (1Y)
-51.9%Volatile

QUALITY

45/100
ROE (avg)
-30.1%Negative
Piotroski F-Score
6/9Average
Debt/Equity
0.30Low leverage
Margin Stability
CV 12.2%Stable
Accruals
-16.1%Cash earnings

MOMENTUM

32/100
6-1M Momentum
-40.4%Negative
1M Return
+20.9%Strong recent gains
Relative Strength
+8.9% vs sectorOutperforming

TECHNICAL

51/100
RSI (14)
55.7Neutral
Price vs SMA200
-8.9%Bearish trend
MACD
-0.05Bearish momentum
Bollinger Band
61%Mid-range
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.197Noisy/choppy

FUNDAMENTALS

32/100
P/FCF
78.8Expensive
P/S
3.8Fair

Macro: neutral (×0.99) - Fear/Greed: 61 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months ★54
3-12 months39
1-5+ years33

Limited short-term thesis

BRAIN47'S ASSESSMENT

I rate Schrödinger, Inc. at 34/100 — a WEAK reading on the Brain47 Signal. The strongest factor is technical at 51/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.

PAST PERFORMANCE

1 MONTH

+20.9%

3 MONTHS

+13.8%

12 MONTHS

—

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Limited short-term thesis. Technical (51) and Quality (45) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 57%. I classify this as a speculative position — elevated volatility at 57% and smaller market cap define the opportunity.

speculativeScore: 34/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.